UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia

Journal of Pediatrics

Volumn 162, Issue 6, 2013, Pages

  Skierka, Jennifer M ^a   Kotzer, Katrina E ^a   Lagerstedt, Susan A ^a   O'Kane, Dennis J ^a   Baudhuin, Linnea M ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CHROMOSOME DUPLICATION; CRIGLER NAJJAR SYNDROME; FEMALE; GENE; GENE DELETION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GILBERT DISEASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HETEROZYGOTE; HUMAN; HYPERBILIRUBINEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEWBORN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; UGT1A1 GENE; UNCONJUGATED HYPERBILIRUBINEMIA;

EID: 84880573155     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.11.042     Document Type: Article

References (42)

1. Clarke DJ, Moghrabi N, Monaghan G, Cassidy A, Boxer M, Hume R, et al. Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias. Clin Chim Acta 1997;266:63-74.
2. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Genetic lesions of bilirubin uridine-diphospho glucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 2000;16:297-306.
3. Strauss KA, Robinson DL, Vreman HJ, Puffenberger EG, Hart G, Morton DH. Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr 2006; 165:306-19.
4. Online Mendelian Inheritance in Man, OMIM. Johns Hopkins University, Baltimore, MD. MIM Number: {191740}. Available at: http://omim.org. Accessed December 14, 2012.
5. Arias IM, Gartner LM, Cohen M, Ben-Ezzer J, Levi AJ. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: evidence for genetic heterogeneity. Trans Assoc Am Physicians 1968;81:66-75.
6. Sinaasappel M, Jansen PL. The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis. Gastroenterology 1991;100:783-9.
7. Chalasani N, Chowdhury NR, Chowdhury JR, Boyer TD. Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect. Gastroenterology 1997;112: 2099-103.
8. Poddar B, Bharti B, Goraya J, Parmar VR. Kernicterus in a child with Crigler-Najjar syndrome type II. Trop Gastroenterol 2002;23:33-4.
9. Thapa BR, Yachha SK, Mehta S. Crigler-Najjar syndrome type II with kernicterus. Indian Pediatr 1987;24:680-3.
10. Ostrow JD. Photocatabolism of labeled bilirubin in the congenitally jaundiced (Gunn) rat. J Clin Invest 1971;50:707-18.
11. Cuperus FJ, Hafkamp AM, Hulzebos CV, Verkade HJ. Pharmacological therapies for unconjugated hyperbilirubinemia. Curr Pharm Des 2009; 15:2927-38.
12. Powell LW, Hemingway E, Billing BH, Sherlock S. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med 1967;277:1108-12.
13. Ando Y, Saka H, Asai G, Sugiura S, Shimokata K, Kamataki T. UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan. Ann Oncol 1998;9:845-7.
14. Iyer L, Hall D, Das S, Mortell MA, Ramirez J, Kim S, et al. Phenotypegenotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther 1999;65:576-82.
15. Mayo Medical laboratories. Mayo Clinic, Rochester, MN; c 1995-2012 [cited 2012 Sept 11]. Available from: http://www.mayomedicallaboratories.com/test- catalog/Clinical+and+Interpretive/81785. Accessed December 20, 2012.
16. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
17. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. Pediatrics 2009;124:1193-8.
18. Skierka JM, O'Kane DJ. UDP-glucuronosyltransferase 1A1 and the glucuronidation in oncology applications and hyperbilirubinemia. Burlington, VT: Elsevier Inc.; 2010.
19. Committee UN. UGT Alleles Nomenclature Home Page. Available at: http://ugtalleles.ulaval.ca, editor. Accessed January 19, 2012.
20. Robarge J, Li L, Desta Z, Nguyen A, Flockhart D. The Star-Allele Nomenclature: Retooling for translational genomics. Clin Pharmacol Therapeut 2007;82:244-8.
21. Di Y, Chan E, Wei M, Liu J, Zhou S. Prediction of Deleterious Non-synonymous Single-Nucleotide Polymorphisms of Human Uridine Diphosphate Glucuronosyltransferase Genes. AAPS 2009; 11:469-80.
22. Elinav H, Israeli E, Shibolet O, Hershko A, Sela C, Migdal A, et al. Idiopathic liver involvement in Turner syndrome. Isr Med Assoc J 2004;6:56-7.
23. Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, et al. Identification of defect in the genes for bilirubin UDP-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 1993;197:1239-44.
24. Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1998; 1406:267-73.
25. Nakagawa T, Mure T, Yusoff S, Ono E, Kusuma Harahap IS, Morikawa S, et al. A homozygous mutation in UGT1A1 exon 5 may be responsible for persistent hyperbilirubinemia in a Japanese girl with Gilbert's syndrome. Kobe J Med Sci 2011;57:E26-31.
26. Sutomo R, Laosombat V, Sadewa AH, Yokoyama N, Nakamura H, Matsuo M, et al. Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. Pediatr Int 2002;44:427-32.
27. Watchko JF. Hyperbilirubinemia in African American neonates: clinical issues and current challenges. Semin Fetal Neonatal Med 2010;15:176-82.
28. Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH, et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 2001;33:1232-8.
29. Ramirez J, Komoroski BJ, Mirkov S, Graber AY, Fackenthal DL, Schuetz EG, et al. Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenet Genomics 2006;16:79-86.
30. Zhang W, He YJ, Gan Z, Fan L, Li Q, Wang A, et al. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation. Clin Exp Pharmacol Physiol 2007;34:1240-4.
31. Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician 2005;72:1277-82.
32. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA 1997;94:12128-32.
33. Lin Z, Fontaine J, Watchko JF. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics 2008;122: e156-62.
34. Chang PF, Lin YC, Liu K, Yeh SJ, Ni YH. Risk of hyperbilirubinemia in breast-fed infants. J Pediatr 2011;159:561-5.
35. Costa E, Vieira E, Lopes AI, Saldanha MJ, Brites D, Dos Santos R. Identification of a novel deletion in UDP-glucuronosyltransferase gene in a patient with Crigler-Najjar syndrome type I. Blood Cells Mol Dis 2009;42:265-6.
36. Ciotti M, Obaray R, Martin MG, Owens IS. Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis. Am J Med Genet 1997;68:173-8.
37. Gagne JF, Montminy V, Belanger P, Journault K, Gaucher G, Guillemette C. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 2002;62:608-17.
38. Iolascon A, Meloni A, Coppola B, Rosatelli MC. Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene. J Med Genet 2000;37:712-3.
39. Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR, et al. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 1994;94:2385-91.
40. Moghrabi N, Clarke DJ, Boxer M, Burchell B. Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler- Najjar syndrome type 2. Genomics 1993;18:171-3.
41. Farheen S, Sengupta S, Santra A, Pal S, Dhali GK, Chakravorty M, et al. Gilbert's syndrome: high frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene. World J Gastroenterol 2006;12:2269-75.
42. Huang CS, Luo GA, Huang ML, Yu SC, Yang SS. Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics 2000;10:539-44.